Radioactive contamination
Some organs concentrate certain elements and hence radionuclide variants of those elements. This action may lead to much lower removal rates. For instance, the thyroid gland takes up a large percentage of any iodine that enters the body. Large quantities of inhaled or ingested radioactive iodine may impair or destroy the thyroid, while other tissues are affected to a lesser extent. Radioactive iodine-131 is a common fission product; it was a major component of the radioactivity released from the Chernobyl disaster, leading to nine fatal cases of pediatric thyroid cancer and hypothyroidism. On the other hand, radioactive iodine is used in the diagnosis and treatment of many diseases of the thyroid precisely because of the thyroid's selective uptake of iodine.
Iodine-131
Due to its mode of beta decay, iodine-131 is notable for causing mutation and death in cells that it penetrates, and other cells up to several millimeters away. For this reason, high doses of the isotope are sometimes less dangerous than low doses, since they tend to kill thyroid tissues that would otherwise become cancerous as a result of the radiation. For example, children treated with moderate dose of I-131 for thyroid adenomas had a detectable increase in thyroid cancer, but children treated with a much higher dose did not. Likewise, most studies of very-high-dose I-131 for treatment of Graves disease have failed to find any increase in thyroid cancer, even though there is linear increase in thyroid cancer risk with I-131 absorption at moderate doses. Thus, iodine-131 is increasingly less employed in small doses in medical use (especially in children), but increasingly is used only in large and maximal treatment doses, as a way of killing targeted tissues. This is known as "therapeutic use".